04-07-2025
Niti to review concerns over pharma quality
Niti Aayog is addressing growing quality concerns in India's pharmaceutical industry by convening industry experts for discussions. The aim is to analyze the current state, understand challenges, and improve the quality of Indian pharmaceutical products to meet global standards. A meeting chaired by VK Paul will propose recommendations to ensure alignment with international regulations and patient safety.
Tired of too many ads?
Remove Ads
Tired of too many ads?
Remove Ads
New Delhi: Growing quality concerns in the pharmaceutical industry has prompted government's think tank Niti Aayog to step in. It has called industry experts to hold discussions with them and undertake an analysis of the current state of India's pharmaceutical industry, to understand the challenges faced by them and initiatives taken by them to ensure production of safe and effective the idea to raise quality of Indian pharmaceutical products to global standards, a meeting will be held on Monday under the chairmanship of member health VK Paul "Ensuring high quality production to meet International regulations and standards has been a challenge," said an office memorandum by Niti Aayog said that a rigorous focus on quality is essential to ensure patient safety and trust in public health in the domestic a meeting to be held on Monday, Dr Paul will propose recommendations to ensure that India's pharmaceutical products are at par with global standards, people in the know told to the memorandum, with the strong network of manufacturing units across the country it is essential to invest in and uphold the highest quality standards for are about 3,000 Pharmaceutical companies and 10,500 manufacturing units across the has long been known as the pharmacy of the world , ranking third globally in drug and pharmaceutical and production by to Niti Aayog, India exports to 200 countries.
